Literature DB >> 21549300

High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function.

Tobias E Herrscher1, Harriet Akre, Britt Øverland, Leiv Sandvik, Arne S Westheim.   

Abstract

BACKGROUND: Sleep-disordered breathing (SDB) is common in patients with reduced ejection fraction (EF). However, little is known about the prevalence of SDB in a general heart failure population including patients with preserved EF (HFPEF).
METHODS: We prospectively enrolled stable heart failure outpatients from our heart failure clinic to assess the prevalence of SDB independent of systolic left ventricular function.
RESULTS: Among 115 patients (62% with reduced EF, 38% with preserved EF, New York Heart Association Class II-IV) SDB was present in 81% (27% central sleep apnea, 54% obstructive sleep apnea [OSA]). HFPEF patients had SDB in 80% of the cases, 62% had OSA. This group had significantly more hypertension.
CONCLUSIONS: This study shows a high prevalence of SDB in a general heart failure population, also in patients with HFPEF. These patients have predominantly OSA. Especially in patients with HFPEF SDB should be kept in mind and referral to a sleep specialist should be considered.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21549300     DOI: 10.1016/j.cardfail.2011.01.013

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  50 in total

1.  Cognitive profiles in heart failure: a cluster analytic approach.

Authors:  Lindsay A Miller; Mary Beth Spitznagel; Michael L Alosco; Ronald A Cohen; Naftali Raz; Lawrence H Sweet; Lisa Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Clin Exp Neuropsychol       Date:  2012-03-01       Impact factor: 2.475

Review 2.  The importance of sleep-disordered breathing in cardiovascular disease.

Authors:  Dominik Linz; Holger Woehrle; Thomas Bitter; Henrik Fox; Martin R Cowie; Michael Böhm; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

Review 3.  Sleep-disordered breathing in patients with heart failure.

Authors:  Robert J Mentz; Mona Fiuzat
Journal:  Heart Fail Clin       Date:  2014-01-10       Impact factor: 3.179

Review 4.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

Review 5.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

6.  Utility of home sleep apnea testing devices in patients with cardiac conditions-critical manual interpretation of the raw data is important.

Authors:  Mukesh Kapoor
Journal:  Sleep Breath       Date:  2019-03-14       Impact factor: 2.816

Review 7.  Obstructive Sleep Apnea in Heart Failure: Review of Prevalence, Treatment with Continuous Positive Airway Pressure, and Prognosis.

Authors:  Himad K Khattak; Faisal Hayat; Salpy V Pamboukian; Harvey S Hahn; Brian P Schwartz; Phyllis K Stein
Journal:  Tex Heart Inst J       Date:  2018-06-01

Review 8.  Sleep apnea, heart failure, and pulmonary hypertension.

Authors:  Sogol Javaheri; Shahrokh Javaheri; Ali Javaheri
Journal:  Curr Heart Fail Rep       Date:  2013-12

9.  Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea.

Authors:  Ritu G Grewal
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

10.  Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.

Authors:  Camilo Toledo; David C Andrade; Claudia Lucero; Alexis Arce-Alvarez; Hugo S Díaz; Valentín Aliaga; Harold D Schultz; Noah J Marcus; Mónica Manríquez; Marcelo Faúndez; Rodrigo Del Rio
Journal:  J Physiol       Date:  2017-03-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.